Dosage Form Design Considerations 2018
DOI: 10.1016/b978-0-12-814423-7.00015-0
|View full text |Cite
|
Sign up to set email alerts
|

Solubility and Solubilization Approaches in Pharmaceutical Product Development

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 176 publications
0
2
0
Order By: Relevance
“…Solubility can also be enhanced by reducing the drug’s MW. Smaller-sized lipophilic drugs (e.g., itraconazole, efavirenz) and hydrophilic agents (e.g., mannitol) are preferably absorbed through the tight junctions in-between epithelial cells [ 49 , 52 , 81 , 82 ].…”
Section: Vaginal Drug Delivery Systems: History and Present Therapeuticsmentioning
confidence: 99%
“…Solubility can also be enhanced by reducing the drug’s MW. Smaller-sized lipophilic drugs (e.g., itraconazole, efavirenz) and hydrophilic agents (e.g., mannitol) are preferably absorbed through the tight junctions in-between epithelial cells [ 49 , 52 , 81 , 82 ].…”
Section: Vaginal Drug Delivery Systems: History and Present Therapeuticsmentioning
confidence: 99%
“…Then the contents were kept with continuous stirring for 8 hours in a water thermostat maintained at the required temperature as described elsewhere [8]. The solution was then filtered and its concentration was determined by titration with standard NaOH solution using phenolphthalein indicator.…”
Section: Chemicalsmentioning
confidence: 99%